CVRX - CVRx Inc logo

CVRx Inc

CVRX
Revenue grew 100% of years5Y
Compare CVRX Hold

CVRx develops, manufactures, and commercializes neuromodulation devices for cardiovascular diseases. Its main product, Barostim, delivers electrical pulses to carotid artery baroreceptors, enhancing baroreflex activation therapy for improved heart function.

โš•๏ธ Healthcare NASDAQ Listed 2021 $ USD
$1,000 invested 5 years ago โ†’$91today

Score Overview

1 Year
Score
Net Growth2.51%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth8.01%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score6.8
Net Growth-20.64%
Net Trend80%
Net Income Consistencyโ€”
Rev Growth369.38%
Rev TrendEvery year
Revenue Consistencyโ€”
All Time
Score
Net Growth-20.64%
Net Trend80%
Net Income Consistency
Rev Growth369.38%
Rev TrendEvery year
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where CVRx Inc has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. CVRX does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-23
$ 1.42โ€”
1 Year2025-10-23
$ 10.08-85.91%
5 Years2021-10-22
$ 15.61-90.90%
All Time2021-06-30
$ 28.00-94.93%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 61M-$ 51M$ 64M
2025$ 56M-$ 53M$ 75M
2024$ 51M-$ 59M$ 105M
2023$ 39M-$ 41M$ 90M
2022$ 22M-$ 41M$ 106M
IPO2021$ 13M-$ 43M$ 142M
CVRX - CVRx Inc logo

CVRx Inc fundamental performance

Between 2021 and 2025, revenue grew from $ 13M to $ 56M and net income went from -$ 43M to -$ 53M. Revenue increased in 100% of the years measured; net income in 80%.

CVRx Inc currently holds a 5-year HDB Score of 6.8 out of 10. How the HDB Score is calculated.

Membership

Explore CVRX with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,112 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies